Citigroup Maintains Neutral Rating for Owens & Minor: Here's What You Need To Know

Citigroup has decided to maintain its Neutral rating of Owens & Minor OMI and raise its price target from $17.00 to $23.00.

Shares of Owens & Minor are trading down 3.35% over the last 24 hours, at $18.00 per share.

A move to $23.00 would account for a 27.74% increase from the current share price.

About Owens & Minor

Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment includes the United States distribution business (Medical Distribution), outsourced logistics and value-added services business, and Global Products business which manufactures and sources medical surgical products through production and kitting operations. The Patient Direct segment includes home healthcare businesses (Byram and Apria).

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.